TOTH FINANCIAL ADVISORY CORP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 866780 LEESBURG, VA

Position in REGN

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$12,470

+$11,698 QoQ

Shares Held

+1900.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,209

of 1,322 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TOTH FINANCIAL ADVISORY CORP holds $11,360,807 across 23 Biotechnology names. REGN ranks #12 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	15,760	$1,786,553
2	KRYS	Krystal Biotech, Inc.	4,511	$1,676,603
3	JAZZ	Jazz Pharmaceuticals plc	6,600	$1,590,402
4	ASND	Ascendis Pharma A/S	5,880	$1,568,313
5	ARGX	Argenx SE	1,323	$1,227,439
6	MIRM	Mirum Pharmaceuticals, Inc.	10,285	$1,204,064
7	MDGL	Madrigal Pharmaceuticals, Inc.	2,000	$1,073,900
8	RYTM	Rhythm Pharmaceuticals, Inc.	7,800	$866,034

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,470	20	+1900.0%	Shares	Sole	2026-07-14
2026-03-31	$772	1	-87.5%	Shares	Sole	2026-04-16
2023-03-31	$6,573	8	-11.1%	Shares	Sole	2023-04-24
2022-06-30	$5,320	9	+80.0%	Shares	Sole	2022-07-25
2022-03-31	$3,492	5	0.0%	Shares	Sole	2022-04-26
2021-12-31	$3,157	5	0.0%	Shares	Sole	2022-01-31
2021-09-30	$3,025	5	0.0%	Shares	Sole	2021-10-20
2021-06-30	$2,792	5	0.0%	Shares	Sole	2021-07-26
2021-03-31	$2,365	5	0.0%	Shares	Sole	2021-04-20
2020-12-31	$2,415	5	0.0%	Shares	Sole	2021-01-25
2020-09-30	$2,798	5	0.0%	Shares	Sole	2020-10-16
2020-06-30	$3,118	5	0.0%	Shares	Sole	2020-07-14
2020-03-31	$2,441	5	—	Shares	Sole	2020-04-20
No filing history on record for this holder in this stock.